$BIIB
BIOGEN INC. Stock $biib

$biib Overview Financials Valuation SEC Filings Company Website

2016 Q3 Form 10-Q Financial Statement

#000087504516000071 Filed on October 26, 2016

Income Statement

Concept	2016 Q3	2015 Q3
Revenue	$2.956B	$2.778B
YoY Change	6.4%	10.61%
Cost Of Revenue	$416.9M	$310.0M
YoY Change	34.48%	2.43%
Gross Profit	$2.539B	$2.468B
YoY Change	2.88%	11.73%
Gross Profit Margin	85.9%	88.84%
Selling, General & Admin	$462.7M	$477.8M
YoY Change	-3.16%	-16.24%
% of Gross Profit	18.22%	19.36%
Research & Development	$529.0M	$519.9M
YoY Change	1.75%	24.62%
% of Gross Profit	20.84%	21.07%
Depreciation & Amortization	$180.2M	$151.6M
YoY Change	18.87%	-13.57%
% of Gross Profit	7.1%	6.14%
Operating Expenses	$991.7M	$997.7M
YoY Change	-0.6%	1.02%
Operating Profit	$1.425B	$1.372B
YoY Change	3.9%	19.02%
Interest Expense	$66.00M	$15.60M
YoY Change	323.08%	110.81%
% of Operating Profit	4.63%	1.14%
Other Income/Expense, Net	-$58.10M	-$15.40M
YoY Change	277.27%	-5.46%
Pretax Income	$1.367B	$1.356B
YoY Change	0.8%	19.37%
Income Tax	$337.0M	$330.1M
% Of Pretax Income	24.65%	24.34%
Net Earnings	$1.033B	$965.6M
YoY Change	6.97%	12.69%
Net Earnings / Revenue	34.94%	34.76%
Basic Earnings Per Share	$4.72	$4.16
Diluted Earnings Per Share	$4.71	$4.15
COMMON SHARES
Basic Shares Outstanding	218.9M shares	232.2M shares
Diluted Shares Outstanding	219.4M shares	232.6M shares

Balance Sheet

Concept	2016 Q3	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.316B	$5.843B
YoY Change	-26.13%	213.97%
Cash & Equivalents	$2.085B	$4.089B
Short-Term Investments	$2.231B	$1.753B
Other Short-Term Assets	$993.1M	$861.9M
YoY Change	15.22%	117.39%
Inventory	$1.010B	$918.9M
Prepaid Expenses
Receivables	$1.468B	$1.328B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$8.092B	$9.271B
YoY Change	-12.72%	112.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.387B	$2.028B
YoY Change	17.71%	17.61%
Goodwill	$3.420B	$2.409B
YoY Change	41.96%	56.3%
Intangibles	$3.870B	$4.181B
YoY Change	-7.45%	1.25%
Long-Term Investments	$4.324B	$2.834B
YoY Change	52.58%	46.92%
Other Assets	$1.240B	$892.2M
YoY Change	38.93%	57.77%
Total Long-Term Assets	$14.01B	$11.46B
YoY Change	22.31%	22.78%
TOTAL ASSETS
Total Short-Term Assets	$8.092B	$9.271B
Total Long-Term Assets	$14.01B	$11.46B
Total Assets	$22.10B	$20.73B
YoY Change	6.64%	51.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$274.0M	$251.2M
YoY Change	9.06%	7.53%
Accrued Expenses	$875.0M	$832.0M
YoY Change	5.17%	-1.77%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.000M	$5.000M
YoY Change	0.0%	66.67%
Total Short-Term Liabilities	$2.500B	$2.634B
YoY Change	-5.1%	35.73%
LONG-TERM LIABILITIES
Long-Term Debt	$6.530B	$6.529B
YoY Change	0.02%	1017.98%
Other Long-Term Liabilities	$862.1M	$861.4M
YoY Change	0.08%	30.86%
Total Long-Term Liabilities	$862.1M	$861.4M
YoY Change	0.08%	30.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.500B	$2.634B
Total Long-Term Liabilities	$862.1M	$861.4M
Total Liabilities	$9.990B	$10.16B
YoY Change	-1.69%	210.44%
SHAREHOLDERS EQUITY
Retained Earnings	$15.03B	$12.00B
YoY Change	25.26%	42.84%
Common Stock	$100.0K	$124.0K
YoY Change	-19.35%	-3.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.612B	$2.612B
YoY Change	0.0%	25.27%
Treasury Stock Shares
Shareholders Equity	$12.12B	$10.57B
YoY Change
Total Liabilities & Shareholders Equity	$22.10B	$20.73B
YoY Change	6.64%	51.26%

Cashflow Statement

Concept	2016 Q3	2015 Q3
OPERATING ACTIVITIES
Net Income	$1.033B	$965.6M
YoY Change	6.97%	12.69%
Depreciation, Depletion And Amortization	$180.2M	$151.6M
YoY Change	18.87%	-13.57%
Cash From Operating Activities	$991.3M	$895.4M
YoY Change	10.71%	-2.05%
INVESTING ACTIVITIES
Capital Expenditures	-$280.7M	-$229.2M
YoY Change	22.47%	266.13%
Acquisitions
YoY Change
Other Investing Activities	$316.9M	-$760.8M
YoY Change	-141.65%	59.16%
Cash From Investing Activities	$36.20M	-$990.0M
YoY Change	-103.66%	83.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-305.3M	2.908B
YoY Change	-110.5%	-8383.76%
NET CHANGE
Cash From Operating Activities	991.3M	895.4M
Cash From Investing Activities	36.20M	-990.0M
Cash From Financing Activities	-305.3M	2.908B
Net Change In Cash	722.2M	2.813B
YoY Change	-74.33%	731.26%
FREE CASH FLOW
Cash From Operating Activities	$991.3M	$895.4M
Capital Expenditures	-$280.7M	-$229.2M
Free Cash Flow	$1.272B	$1.125B
YoY Change	13.11%	15.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	biib	Adjustments To Product Revenue Reserves Relating To Sales In Prior Years AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears	26800000	USD
CY2015Q4	biib	Available For Sale Securities Debt Maturities After Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost	185300000	USD
CY2016Q3	biib	Available For Sale Securities Debt Maturities After Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost	281300000	USD
CY2015Q4	biib	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	184500000	USD
CY2016Q3	biib	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	281400000	USD
CY2015	biib	Average Maturity Of Marketable Securities AverageMaturityOfMarketableSecurities	P16M
	biib	Average Maturity Of Marketable Securities AverageMaturityOfMarketableSecurities	P14M
CY2015Q3	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	0	USD
	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	0	USD
CY2016Q3	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	4700000	USD
	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	-900000	USD
	biib	Current Provisions To Product Revenue Reserves Relating To Sales In Current Year CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear	1944000000	USD
CY2015Q4	biib	Duefromanti Cd20therapeuticprograms DuefromantiCD20therapeuticprograms	314500000	USD
CY2016Q3	biib	Duefromanti Cd20therapeuticprograms DuefromantiCD20therapeuticprograms	305200000	USD
CY2015Q3	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.021
	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.020
CY2016Q3	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.018
	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.017
CY2015Q2	biib	Employeestockpurchaseplanmaximumshares Employeestockpurchaseplanmaximumshares	6200000	shares
	biib	Interest In Subsidiary InterestInSubsidiary	1.00
CY2015Q4	biib	Inventorynetcurrentandnoncurrent Inventorynetcurrentandnoncurrent	933600000	USD
CY2016Q3	biib	Inventorynetcurrentandnoncurrent Inventorynetcurrentandnoncurrent	1049500000	USD
CY2015Q3	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	300000	USD
CY2015Q4	biib	Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities	29200000	USD
CY2016Q3	biib	Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities	39200000	USD
CY2016Q3	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	100000	USD
	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	100000	USD
CY2015Q4	biib	Overnightreverserepurchaseagreementspercentoftotalassets Overnightreverserepurchaseagreementspercentoftotalassets	0.007
CY2016Q3	biib	Overnightreverserepurchaseagreementspercentoftotalassets Overnightreverserepurchaseagreementspercentoftotalassets	0.002
	biib	Payments Returns Applied Against Product Revenue Reserves Relating To Current Year PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear	1466400000	USD
	biib	Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear	575100000	USD
CY2015Q3	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	337200000	USD
	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	1005300000	USD
CY2016Q3	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	317600000	USD
	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	996300000	USD
CY2015Q3	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	25500000	USD
	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	159200000	USD
CY2016Q3	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	50700000	USD
	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	147700000	USD
CY2015Q4	biib	Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax	1800000	USD
CY2016Q3	biib	Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax	15000000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000875045
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	217574479	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	BIOGEN INC.
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	267400000	USD
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	274000000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1227000000	USD
CY2016Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1467800000	USD
CY2015Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	167900000	USD
CY2016Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	209000000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1330100000	USD
CY2016Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1528400000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-59500000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-157400000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-224000000	USD
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-300900000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	USD
CY2016Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	28300000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	167600000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	53900000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	158400000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	98100000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	286000000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	99700000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	281400000	USD
CY2015Q4	us-gaap	Assets Assets	19504800000	USD
CY2016Q3	us-gaap	Assets Assets	22104900000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	6700300000	USD
CY2016Q3	us-gaap	Assets Current AssetsCurrent	8091800000	USD
CY2015Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	4891200000	USD
CY2016Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	5322300000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	4880900000	USD
CY2016Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	5328100000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	300000	USD
CY2016Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	8200000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	10600000	USD
CY2016Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2400000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	4891200000	USD
CY2016Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	5322300000	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	2120500000	USD
CY2016Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	2231200000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	2583900000	USD
CY2016Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	2810200000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2575900000	USD
CY2016Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2815500000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2122000000	USD
CY2016Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2230800000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2120500000	USD
CY2016Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2231200000	USD
CY2015Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	700000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	1300000	USD
CY2016Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	1100000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	2100000	USD
CY2015Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	2000000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	2900000	USD
CY2016Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1100000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	2700000	USD
CY2015Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	2760400000	USD
CY2016Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	3096900000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	504700000	USD
CY2016Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	570500000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	301300000	USD
CY2016Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	251100000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1204900000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4089000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1308000000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2084800000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2914400000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	776100000	USD
CY2015Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	909500000	USD
CY2016Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1736400000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2016Q3	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	909200000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2617500000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1014800000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2976700000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-53600000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-49100000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2600000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	5700000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	962800000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2666600000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1012200000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2971000000	USD
CY2015Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	310000000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	908600000	USD
CY2016Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	416900000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1100200000	USD
CY2015Q3	us-gaap	Costs And Expenses CostsAndExpenses	1406000000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4201700000	USD
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	1530500000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4312600000	USD
CY2015Q4	us-gaap	Debt Current DebtCurrent	4800000	USD
CY2016Q3	us-gaap	Debt Current DebtCurrent	4900000	USD
CY2015Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	6645900000	USD
CY2016Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	7206100000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-185800000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-56800000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	124900000	USD
CY2016Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	98700000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	444100000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	505300000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	11.60
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	13.95
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	11.57
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	13.92
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-30300000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	700000	USD
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.243
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.246
CY2016Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.247
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.256
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.107
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.101
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.101
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.094
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.015
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.012
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.012
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.011
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.005
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.006
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.002
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.005
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.005
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.004
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.012
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.005
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.011
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.011
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.009
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.014
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.013
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	270800000	USD
CY2016Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	282700000	USD
CY2015Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2800000	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	8400000	USD
CY2016Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	3200000	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	10700000	USD
CY2015Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	6400000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	46000000	USD
CY2016Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	14600000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	42500000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	70800000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	11900000	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-200000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-5900000	USD
CY2016Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-5900000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-18800000	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	274500000	USD
CY2016Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	14500000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	14500000	USD
CY2016Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	3200000	USD
	us-gaap	Fair Value Measurements Changes In Valuation Techniques FairValueMeasurementsChangesInValuationTechniques	0
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3561200000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3842600000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	347800000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	92800000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	247700000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	265600000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	301900000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	321400000	USD
CY2015Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4300000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-18800000	USD
CY2016Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4900000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2600000	USD
CY2015Q3	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	8100000	USD
	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	4200000	USD
CY2016Q3	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	400000	USD
	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	16600000	USD
CY2015Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	1100000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-300000	USD
CY2016Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	800000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-300000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	2663800000	USD
CY2016Q3	us-gaap	Goodwill Goodwill	3419700000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	771300000	USD
CY2016Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-15400000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1356400000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3681500000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1367200000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4094800000	USD
CY2015Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6800000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12500000	USD
CY2016Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	330100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	904500000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	337000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1047000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	63600000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	238100000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1200000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-147400000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-174500000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-223200000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	150400000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	155100000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	120500000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-62100000	USD
CY2015Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7646300000	USD
CY2016Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7712500000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4085100000	USD
CY2016Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3869900000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	15600000	USD
	us-gaap	Interest Expense InterestExpense	28100000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	66000000	USD
	us-gaap	Interest Expense InterestExpense	195200000	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	143000000	USD
CY2016Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	171100000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	893400000	USD
CY2016Q3	us-gaap	Inventory Net InventoryNet	1009700000	USD
CY2015Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	40200000	USD
CY2016Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	39800000	USD
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	213000000	USD
CY2016Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	166400000	USD
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	577600000	USD
CY2016Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	712000000	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	5400000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	13000000	USD
CY2016Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	16400000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	43000000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	10129900000	USD
CY2016Q3	us-gaap	Liabilities Liabilities	9990100000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19504800000	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22104900000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2577700000	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2499700000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	6521500000	USD
CY2016Q3	us-gaap	Long Term Debt LongTermDebt	6529600000	USD
	us-gaap	Maximum Remaining Maturity Of Foreign Currency Derivatives1 MaximumRemainingMaturityOfForeignCurrencyDerivatives1	P15M
CY2014Q4	us-gaap	Minority Interest MinorityInterest	5000000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1200000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-5400000	USD
CY2015Q2	us-gaap	Minority Interest MinorityInterest	400000	USD
CY2015Q3	us-gaap	Minority Interest MinorityInterest	-5800000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	2100000	USD
CY2016Q2	us-gaap	Minority Interest MinorityInterest	-100000	USD
CY2016Q3	us-gaap	Minority Interest MinorityInterest	-2700000	USD
CY2015Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	60000000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	60000000	USD
CY2016Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	0	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2984800000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-266600000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2746100000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1903100000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2675700000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2945800000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	965600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2715400000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	1032900000	USD
	us-gaap	Net Income Loss NetIncomeLoss	3053600000	USD
CY2015Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	53900000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	49100000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2700000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5800000	USD
CY2015Q3	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	200000	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	100000	USD
CY2016Q3	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	900000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15400000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-41300000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-58100000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-169400000	USD
CY2015Q4	us-gaap	Notes Payable NotesPayable	6506500000	USD
CY2016Q3	us-gaap	Notes Payable NotesPayable	6516000000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1371800000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	3722800000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1425300000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	4264200000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	635300000	USD
CY2016Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	566800000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	836900000	USD
CY2016Q3	us-gaap	Other Assets Current OtherAssetsCurrent	993100000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1107600000	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1239600000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2200000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1600000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	19700000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-78200000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-31200000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-40100000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	1300000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-17000000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-23500000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-61300000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-14400000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-62800000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-56400000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-97900000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-18100000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-76900000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-500000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-4600000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-400000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1300000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2096800000	USD
CY2016Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2012000000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	905800000	USD
CY2016Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	862100000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-31600000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-33400000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7100000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4400000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14300000	USD
CY2015Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	49000000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	156600000	USD
CY2016Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	98600000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	265500000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	27400000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	12800000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2998200000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	348900000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	4870100000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	5631700000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	198800000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6300000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	110400000	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	550000000	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	900000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	456900000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	434000000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Taxes PrepaidTaxes	550600000	USD
CY2016Q3	us-gaap	Prepaid Taxes PrepaidTaxes	725300000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	45500000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	35200000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5930900000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-62100000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	37900000	USD
CY2015Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	2387900000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	3363400000	USD
CY2016Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	2362200000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	5185800000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	1019500000	USD
	us-gaap	Profit Loss ProfitLoss	2764500000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	1030200000	USD
	us-gaap	Profit Loss ProfitLoss	3047800000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2187600000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2387000000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-117700000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	1300000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2100000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2700000	USD
CY2015Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	519900000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1471100000	USD
CY2016Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	529000000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1439400000	USD
CY2015Q3	us-gaap	Restructuring Charges RestructuringCharges	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2016Q3	us-gaap	Restructuring Charges RestructuringCharges	11600000	USD
	us-gaap	Restructuring Charges RestructuringCharges	21300000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12208400000	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15030000000	USD
CY2015Q3	us-gaap	Revenues Revenues	2777900000	USD
	us-gaap	Revenues Revenues	7924500000	USD
CY2016Q3	us-gaap	Revenues Revenues	2955800000	USD
	us-gaap	Revenues Revenues	8576800000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2391700000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6762600000	USD
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2539600000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7315000000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	477800000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1530100000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	462700000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1452400000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	131500000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	117800000	USD
CY2015Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000000	USD
CY2016Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000000	USD
CY2016Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1300000	shares
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	9372800000	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	12117500000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9374900000	USD
CY2016Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12114800000	USD
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	2739900000	USD
CY2015Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	208700000	USD
CY2016Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	208800000	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	9700000	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1100000	shares
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2611700000	USD
CY2016Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2611700000	USD
CY2015Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	24000000	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	662700000	USD
CY2016Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	538400000	USD
CY2015Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	400000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	600000	shares
CY2016Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	500000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	400000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	232600000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	234700000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	219400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	219400000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	232200000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	234100000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	218900000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	219000000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
biib-2016930collab.jpg	Edgar Link	pending
0000875045-16-000071-index-headers.html	Edgar Link	pending
0000875045-16-000071-index.html	Edgar Link	pending
0000875045-16-000071.txt	Edgar Link	pending
0000875045-16-000071-xbrl.zip	Edgar Link	pending
biib-20160930.xml	Edgar Link	completed
biib-20160930.xsd	Edgar Link	pending
biib-20160930_cal.xml	Edgar Link	unprocessable
biib-20160930_def.xml	Edgar Link	unprocessable
biib-20160930_lab.xml	Edgar Link	unprocessable
biib-20160930_pre.xml	Edgar Link	unprocessable
biib-2016930alprolix.jpg	Edgar Link	pending
biib-2016930amortization.jpg	Edgar Link	pending
biib-2016930anticd20.jpg	Edgar Link	pending
biib-2016930biosimilars.jpg	Edgar Link	pending
biib-2016930cos.jpg	Edgar Link	pending
biib-2016930eloctate.jpg	Edgar Link	pending
biib-2016930equityinloss.jpg	Edgar Link	pending
biib-2016930gainlossfv.jpg	Edgar Link	pending
biib-2016930highlights.jpg	Edgar Link	pending
biib-2016930incometax.jpg	Edgar Link	pending
biib-2016930interferons.jpg	Edgar Link	pending
biib-2016930nci.jpg	Edgar Link	pending
biib-2016930oie.jpg	Edgar Link	pending
biib-2016930otherrevenues.jpg	Edgar Link	pending
biib-2016930rd.jpg	Edgar Link	pending
biib-2016930rdpiechart2015.jpg	Edgar Link	pending
biib-2016930rdpiechart2016.jpg	Edgar Link	pending
biib-2016930reserves.jpg	Edgar Link	pending
biib-2016930restructuring.jpg	Edgar Link	pending
biib-2016930sga.jpg	Edgar Link	pending
biib-2016930tecfidera.jpg	Edgar Link	pending
biib-2016930tysabri.jpg	Edgar Link	pending
biib-2016930x10q.htm	Edgar Link	pending
biib-2016930xex311.htm	Edgar Link	pending
biib-2016930xex312.htm	Edgar Link	pending
biib-2016930xex321.htm	Edgar Link	pending
biib-2016930zinbryta.jpg	Edgar Link	pending
biogenlogostandarda05.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIIB
BIOGEN INC. Stock $biib

2016 Q3 Form 10-Q Financial Statement

#000087504516000071 Filed on October 26, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIIB BIOGEN INC. Stock $biib

2016 Q3 Form 10-Q Financial Statement

#000087504516000071 Filed on October 26, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIIB
BIOGEN INC. Stock $biib